Therefore, the aims of our study were to assess the efficacy of ATM-AVI combination against an NDM-1 plus CTX-M-15 producing Escherichia coli strain, by comparison to its activity against β-lactam susceptible parental strain, in a murine model of peritonitis at standard and high inocula. The gene discussed is ATM; the disease is peritonitis.